Insulet Corporation ($PODD) Stock Forecast: Down 5.7% Today

What is Insulet Corporation?

Insulet Corporation (NASDAQ: PODD) specializes in wearable devices for insulin management. The stock experienced a strong bearish movement today.

Why is Insulet Corporation going down?

PODD stock is down 5.7% on Nov 6, 2025 15:41

• Increased short interest in Insulet Corp (PODD) potentially contributed to the bearish movement.
• Wall Street estimates for key metrics ahead of Insulet's Q3 earnings may have fallen short, affecting investor sentiment.
• The overall market performance and potential profit-taking activities likely influenced the bearish movement in Insulet's stock.
• Investors might be reacting to current market conditions and short-term factors impacting Insulet's stock price negatively, despite its historical outperformance.

PODD Price Chart

PODD Technical Analysis

PODD News

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' - Apollo Asset Management ( NYSE:APO ) , Insulet ( NASDAQ:PODD )

On CNBC's "Halftime Report Final Trades," Joseph Terranova, senior managing director at Virtus Investment Partners, named Insulet Corporation ( NASDAQ:PODD ) , a maker of wearable devices for insulin management, as his final trade.

https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48651192/insulet-uber-and-a-financial-stock-on-cnbcs-final-trades

Ahead of Insulet ( PODD ) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

https://www.zacks.com/stock/news/2784435/ahead-of-insulet-podd-q3-earnings-get-ready-with-wall-street-estimates-for-key-metrics

Peering Into Insulet Corp's Recent Short Interest - Insulet ( NASDAQ:PODD )

Insulet Corp's ( NYSE:PODD ) short interest as a percent of float has risen 10.48% since its last report. According to exchange reported data, there are now 1.61 million shares sold short, which is 3.48% of all regular shares that are available for trading.

https://www.benzinga.com/insights/short-sellers/25/10/48562569/peering-into-insulet-corps-recent-short-interest

$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today - Insulet ( NASDAQ:PODD )

Insulet ( NASDAQ:PODD ) has outperformed the market over the past 15 years by 10.68% on an annualized basis producing an average annual return of 22.81%. Currently, Insulet has a market capitalization of $22.26 billion.

https://www.benzinga.com/insights/news/25/10/48535076/100-invested-in-insulet-15-years-ago-would-be-worth-this-much-today

Trending Today

XRP ($XRP) Crypto Forecast: Down 5.2% Today

Internet Computer ($ICP) Crypto Forecast: Up 43.9% Today

Tezos ($XTZ) Crypto Forecast: Up 16.4% Today

Filecoin ($FIL) Crypto Forecast: Up 50.3% Today

Dash ($DASH) Crypto Forecast: Up 21.3% Today

Solana ($SOL) Crypto Forecast: Down 5.5% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.4% Today

Evergy Inc. ($EVRG) Stock Forecast: Down 1.9% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 5.5% Today

Novo Nordisk A/S ($NVO) Stock Forecast: Down 5.2% Today

Insulet Corporation Price History

20.11.2024 - PODD Stock was up 5.1%

• Insulet (PODD) displayed a solid bullish movement in the market today.
• Insulet's impressive 15-year performance, exceeding the market by 9.66% annually, was noted.
• The company's longstanding success and market outperformance likely influenced the positive movement of PODD today.
• Investor optimism regarding Insulet's future growth potential is believed to have bolstered buying activity and propelled the stock price upwards.

09.04.2025 - PODD Stock was up 14.4%

• Exceeded earnings and revenue expectations for Q1, indicating strong financial performance.
• The positive surprise in earnings and revenues suggests that the company's insulin delivery systems are in high demand.
• Investors may be optimistic about the future prospects of Insulet (PODD) based on these strong financial results.
• The bullish movement in the stock price could be attributed to the market's positive reaction to the company's impressive performance in Q1.

24.03.2025 - PODD Stock was up 5.2%

• Insulet (PODD) has delivered impressive performance over the last 15 years, consistently outperforming the market by 10.59% on an annual basis with an average return of 21.0%.
• The stock's upward movement today could be linked to Insulet's sustained growth and solid market capitalization of $17.14 billion.
• Investor optimism regarding Insulet's future within the medical device sector may have heightened, resulting in increased buying activity and pushing the stock price upwards.

21.01.2025 - PODD Stock was down 1.6%

• Insulet (PODD) recently announced positive earnings and revenue figures that exceeded expectations, but the stock saw a decline in value.
• This decline could be attributed to investors selling off their shares to lock in profits, possibly indicating high expectations that were not fully met.
• Concerns about future growth potential or guidance provided by the company may have also influenced the downward trajectory of the stock.
• External market conditions or general sentiments within the healthcare industry might have played a role in the stock's negative performance.

07.07.2025 - PODD Stock was up 9.2%

• Insulet (PODD) stock experienced a strong bullish movement today, possibly driven by positive market sentiment and investor optimism.
• The anticipation of strong Q2 performance and earnings growth expectations by financial analysts could have contributed to the bullish momentum.
• The long-term outperformance of Insulet stock over the past decade, with an average annual return of 23.62%, may have attracted investors seeking growth opportunities.
• Overall, the combination of positive market expectations, strong historical performance, and an upcoming earnings report could have fueled the bullish movement in Insulet (PODD) stock today.

07.07.2025 - PODD Stock was up 5.7%

• In Q2, Insulet (PODD) surpassed both earnings and revenue forecasts, demonstrating robust financial performance.
• The stock has consistently outperformed the market over the last ten years, with a notable average annual return, indicating a reliable performance history.
• The stock's price increase today is likely influenced by the favorable quarterly results and sustained market outperformance.
• Investors show confidence in Insulet's growth potential, backed by its strong financial performance and market positioning in the diabetes management sector.

18.01.2025 - PODD Stock was up 0.8%

• Insulet (PODD) had a strong bullish movement today, potentially driven by positive insights from analysts regarding the company's Q4 earnings.
• The market may have reacted positively to projections for key metrics, indicating a strong performance for the quarter ended December 2024.
• Investors might be optimistic about the company's growth prospects and financial health, leading to increased buying interest in Insulet's stock.
• Overall, the bullish movement in PODD could be attributed to favorable expectations surrounding the company's financial performance and strategic direction.

25.01.2025 - PODD Stock was down 5.9%

• Despite posting strong Q4 earnings and revenues exceeding expectations, Insulet Corporation (PODD) saw a downtrend in its stock price.
• Profit-taking by investors following a robust performance may have triggered the negative market response, causing a temporary decline.
• Concerns about future growth potential or external economic factors affecting the healthcare sector could have spurred the selling pressure on Insulet's stock.
• Shifts in market sentiment possibly driven by factors beyond the company's performance, such as overall market trends or geopolitical events, may have contributed to today's bearish movement in PODD stock.

06.10.2025 - PODD Stock was down 5.7%

• Increased short interest in Insulet Corp (PODD) potentially contributed to the bearish movement.
• Wall Street estimates for key metrics ahead of Insulet's Q3 earnings may have fallen short, affecting investor sentiment.
• The overall market performance and potential profit-taking activities likely influenced the bearish movement in Insulet's stock.
• Investors might be reacting to current market conditions and short-term factors impacting Insulet's stock price negatively, despite its historical outperformance.

08.07.2025 - PODD Stock was up 5.7%

• Insulet (PODD) posted robust Q2 results, surpassing revenue projections and revising its annual sales forecast upwards. This strong financial showing likely bolstered investor confidence in the company's growth potential, contributing to the stock's favorable performance.
• The company's consistent outperformance over the past ten years, as noted in insights on its historical stock returns, may have also enticed investors looking for sustainable growth opportunities.
• The market's optimistic response to Insulet's earnings beat and raised guidance indicates confidence in the adoption of its insulin pump products, especially the Omnipod 5, pointing towards a promising future performance for the company.

29.03.2025 - PODD Stock was down 5.4%

• The decrease in Insulet's stock (PODD) value is possibly linked to a recent downgrade by a prominent Wall Street analyst, triggering a change in market sentiment.
• Despite its track record of strong performance and consistent annual returns, investors seem to be responding to the recent rating downgrade and repositioning their investments.
• With a market capitalization of $17.14 billion, Insulet holds a substantial position in the medical device sector. However, current influences like analyst evaluations can still impact its stock performance in the short term.

01.09.2025 - PODD Stock was down 5.8%

• Despite today's decline, Insulet Inc. (PODD) has witnessed a notable 37.4% increase in its stock value in the last year.
• The current decrease in stock price may be linked to investors taking profits following a sustained growth period.
• Key drivers like the introduction of Omnipod 5, global expansion, and enhanced presence in diabetes care have fueled the stock's upward movement in the past year.
• Investors could be reconsidering their positions in PODD stock, contributing to the recent bearish trend, possibly influenced by a wider market adjustment or sector repositioning.